Oncogene-Targeting T Cells Reject Large Tumors while Oncogene Inactivation Selects Escape Variants in Mouse Models of Cancer
- 1 December 2011
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 20 (6) , 755-767
Abstract
No abstract availableKeywords
Funding Information
- Sixth Framework Programme
- Human Growth Foundation (HA-202)
- Deutsche Forschungsgemeinschaft (SFB TR36)
This publication has 45 references indexed in Scilit:
- CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene InactivationCancer Cell, 2010
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T CellsCancer Research, 2010
- Targeting the cancer kinome through polypharmacologyNature Reviews Cancer, 2010
- LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factorJournal of Cell Science, 2009
- Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsivenessJournal of Experimental Medicine, 2008
- IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancersJournal of Clinical Investigation, 2008
- Clonal Integration of a Polyomavirus in Human Merkel Cell CarcinomaScience, 2008
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLOS Medicine, 2005
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000